D
MiNK Therapeutics, Inc. INKT
$14.57 -$0.33-2.22% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -53.17% -12.33% -36.34% 33.13% 29.15%
Total Depreciation and Amortization -3.94% -5.75% -13.90% 38.80% -16.17%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 85.27% 11.52% 159.03% -367.22% -25.28%
Change in Net Operating Assets 97.51% 2,861.68% 64.33% 24.62% -112.82%
Cash from Operations -17.03% 22.39% 42.31% -30.74% 9.89%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- -100.00%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -16.67% -- -- -99.88% 84,049.28%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -16.67% -- -100.00% -99.88% 15.97%
Foreign Exchange rate Adjustments 972.22% 92.34% -970.37% 114.21% -28.38%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -15.71% 23.36% 41.34% -185.38% 42.72%